An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents
NCT ID: NCT01825694
Last Updated: 2023-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
117 participants
INTERVENTIONAL
2013-04-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that the intervention group, compared to the control group, will reduce substance use and symptoms for traumatic stress.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dismantling the Components and Dosing of CBT for Co-Occurring Disorders
NCT02161211
Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse
NCT00108407
Bringing What Works to Youth in Corrections: A Trauma Intervention
NCT01560728
Sequenced vs. Integrated Delivery of Treatment for Adolescent Depression and SUD
NCT00680966
Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment
NCT06858527
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care
The Standard of Care condition includes: 1) an individual session with the counselor, once per week; 2) a treatment group with the counselor, twice per week; and 3) parents of youth are invited to attend parent-only educational sessions weekly.
No interventions assigned to this group
Trauma-focused Substance Abuse Intervention
See Intervention Arm description.
Trauma-focused Substance Abuse Intervention
An integrated treatment approach to reduce substance use and PTSD symptoms. The intervention program includes: 1) 1-2 individual sessions during which youth talk about the trauma, during the course of the intervention program; 2) 16 group sessions for youth; 3) 2 conjoint sessions with parents to improve communication and problem-solving skills; and 4) 2 parent-education group sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trauma-focused Substance Abuse Intervention
An integrated treatment approach to reduce substance use and PTSD symptoms. The intervention program includes: 1) 1-2 individual sessions during which youth talk about the trauma, during the course of the intervention program; 2) 16 group sessions for youth; 3) 2 conjoint sessions with parents to improve communication and problem-solving skills; and 4) 2 parent-education group sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* meeting DSM IV criteria for substance abuse/dependence and PTSD;
* previously enrolled at recruitment site for at least 2 weeks;
* parent/guardian provides permission for minors to participate.
* Age 18 or above;
Exclusion Criteria
* presence of organic brain damage;
* inability to understand enrollment forms (e.g. Informed Assent/Consent Form)
* presence of organic brain damage.
13 Years
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy S Wu, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Behavioral Health Services
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.